tickertape
← runs

CVS

CVS HEALTH Corpeval run
10-K for period ending 2025-12-31gpt-6-luna@none · prompt v4$0.00106.5sfiling on sec.gov ↗

figures

fieldvaluestatement rowprintedSEC
Total revenue$402.1BR7 Total revenues402,067 millions$402.1B ✓
Operating income$4.7BR16 Operating income4,660 millions$4.7B ✓
Net income attributable to the company$1.8BR25 Net income attributable to CVS Health1,768 millions$1.8B ✓
Diluted EPS$1.39R28 Diluted1.39$1.39 ✓
Cash and cash equivalents$8.5BR3 Cash and cash equivalents8,453 millions$8.5B ✓
Total assets$253.5BR16 Total assets253,538 millions$253.5B ✓
Total liabilities$178.2BR33 Total liabilities178,156 millions$178.2B ✓
Total shareholders' equity attributable to the company$75.2BR41 Total CVS Health shareholders’ equity75,214 millions$75.2B ✓
Net cash from operating activities$10.6BR10 Net cash provided by operating activities10,639 millions$10.6B ✓
Net cash from investing activities-$5.9BR17 Net cash used in investing activities(5,871) millions-$5.9B ✓
Net cash from financing activities-$4.9BR29 Net cash provided by (used in) financing activities(4,940) millions-$4.9B ✓

checks

  • assets = liabilities + equity · total assets equals total liabilities and equity
  • equity excludes minority interests · totalEquity excludes noncontrolling interests
  • net income is before preferred dividends · net income is not the after-preferred-dividends line
  • diluted EPS is for total net income · diluted EPS is for total net income
  • net income excludes minority interests · netIncome excludes noncontrolling interests
  • cash flows tie to the change in cash · operating + investing + financing (+ FX) equals the net change in cash

management's claims

Found 4 claims, none about a company-wide figure the statements can confirm.

trace

  1. 0locator (code)0.26s
    {
  "tables": 121,
  "exhibits": [],
  "documents": 1
}
    {
  "income": {
    "rows": 32,
    "scale": 1000000,
    "score": 51.75,
    "heading": "92 Index to Consolidated Financial Statements Consolidated Statements of Operations",
    "tableIndex": 26,
    "runnerUpScore": 25.75
  },
  "balance": {
    "rows": 45,
    "scale": 1000000,
    "score": 54.75,
    "heading": "ng notes to consolidated financial statements. 94 Index to Consolidated Financial Statements Consolidated Balance Sheets",
    "tableIndex": 28,
    "runnerUpScore": 21.5
  },
  "cashflow": {
    "rows": 33,
    "scale": 1000000,
    "score": 52.25,
    "heading": "o consolidated financial statements. 95 Index to Consolidated Financial Statements Consolidated Statements of Cash Flows",
    "tableIndex": 29,
    "runnerUpScore": 10
  }
}
  2. 1cash flow agent1.96s · 1412 tokens · $0.0002
    {
  "rows": 33,
  "retryHint": null,
  "tableIndex": 29
}
    {
  "figures": [
    {
      "note": "This is the operating-activities section total.",
      "field": "operatingCashFlow",
      "scale": 1000000,
      "value": 10639000000,
      "printed": "10,639",
      "rowIndex": 10,
      "rowLabel": "Net cash provided by operating activities",
      "priorValue": 9107000000,
      "agentPrinted": "10,639",
      "failedChecks": [],
      "priorPrinted": "9,107",
      "groundingMismatch": false
    },
    {
      "note": "This is the investing-activities section total.",
      "field": "investingCashFlow",
      "scale": 1000000,
      "value": -5871000000,
      "printed": "(5,871)",
      "rowIndex": 17,
      "rowLabel": "Net cash used in investing activities",
      "priorValue": -7613000000,
      "agentPrinted": "(5,871)",
      "failedChecks": [],
      "priorPrinted": "(7,613)",
      "groundingMismatch": false
    },
    {
      "note": "This is the financing-activities section total.",
      "field": "financingCashFlow",
      "scale": 1000000,
      "value": -4940000000,
      "printed": "(4,940)",
      "rowIndex": 29,
      "rowLabel": "Net cash provided by (used in) financing activities",
      "priorValue": -1135000000,
      "agentPrinted": "(4,940)",
      "failedChecks": [],
      "priorPrinted": "(1,135)",
      "groundingMismatch": false
    }
  ],
  "statement": "cashflow",
  "tableIndex": 29,
  "priorColumn": 1,
  "currentColumn": 0
}
  3. 2income statement agent2.01s · 1580 tokens · $0.0002
    {
  "rows": 32,
  "retryHint": null,
  "tableIndex": 26
}
    {
  "figures": [
    {
      "note": "Total revenues is the company-wide revenue line, including investment income as specified for insurers.",
      "field": "revenue",
      "scale": 1000000,
      "value": 402067000000,
      "printed": "402,067",
      "rowIndex": 7,
      "rowLabel": "Total revenues",
      "priorValue": 372809000000,
      "agentPrinted": "402,067",
      "failedChecks": [],
      "priorPrinted": "372,809",
      "groundingMismatch": false
    },
    {
      "note": "This is the explicitly reported operating income line.",
      "field": "operatingIncome",
      "scale": 1000000,
      "value": 4660000000,
      "printed": "4,660",
      "rowIndex": 16,
      "rowLabel": "Operating income",
      "priorValue": 8516000000,
      "agentPrinted": "4,660",
      "failedChecks": [],
      "priorPrinted": "8,516",
      "groundingMismatch": false
    },
    {
      "note": "This line reports net income attributable to CVS Health, excluding noncontrolling interests.",
      "field": "netIncome",
      "scale": 1000000,
      "value": 1768000000,
      "printed": "1,768",
      "rowIndex": 25,
      "rowLabel": "Net income attributable to CVS Health",
      "priorValue": 4614000000,
      "agentPrinted": "1,768",
      "failedChecks": [],
      "priorPrinted": "4,614",
      "groundingMismatch": false
    },
    {
      "note": "This is diluted earnings per share attributable to CVS Health.",
      "field": "epsDiluted",
      "scale": 1,
      "value": 1.39,
      "printed": "1.39",
      "rowIndex": 28,
      "rowLabel": "Diluted",
      "priorValue": 3.66,
      "agentPrinted": "1.39",
      "failedChecks": [],
      "priorPrinted": "3.66",
      "groundingMismatch": false
    }
  ],
  "statement": "income",
  "tableIndex": 26,
  "priorColumn": 1,
  "currentColumn": 0
}
  4. 3balance sheet agent2.16s · 1590 tokens · $0.0002
    {
  "rows": 45,
  "retryHint": null,
  "tableIndex": 28
}
    {
  "figures": [
    {
      "note": "This is the balance-sheet cash and cash equivalents line.",
      "field": "cash",
      "scale": 1000000,
      "value": 8453000000,
      "printed": "8,453",
      "rowIndex": 3,
      "rowLabel": "Cash and cash equivalents",
      "priorValue": 8586000000,
      "agentPrinted": "8,453",
      "failedChecks": [],
      "priorPrinted": "8,586",
      "groundingMismatch": false
    },
    {
      "note": "This row explicitly reports total assets.",
      "field": "totalAssets",
      "scale": 1000000,
      "value": 253538000000,
      "printed": "253,538",
      "rowIndex": 16,
      "rowLabel": "Total assets",
      "priorValue": 253215000000,
      "agentPrinted": "253,538",
      "failedChecks": [],
      "priorPrinted": "253,215",
      "groundingMismatch": false
    },
    {
      "note": "This is the printed total liabilities line, not total liabilities and equity.",
      "field": "totalLiabilities",
      "scale": 1000000,
      "value": 178156000000,
      "printed": "178,156",
      "rowIndex": 33,
      "rowLabel": "Total liabilities",
      "priorValue": 177485000000,
      "agentPrinted": "178,156",
      "failedChecks": [],
      "priorPrinted": "177,485",
      "groundingMismatch": false
    },
    {
      "note": "This is the company-attributable CVS Health shareholders’ equity, excluding noncontrolling interests.",
      "field": "totalEquity",
      "scale": 1000000,
      "value": 75214000000,
      "printed": "75,214",
      "rowIndex": 41,
      "rowLabel": "Total CVS Health shareholders’ equity",
      "priorValue": 75560000000,
      "agentPrinted": "75,214",
      "failedChecks": [],
      "priorPrinted": "75,560",
      "groundingMismatch": false
    }
  ],
  "statement": "balance",
  "tableIndex": 28,
  "priorColumn": 1,
  "currentColumn": 0
}
  5. 4reconciler (code)0.00s
    null
    [
  {
    "name": "balance_identity",
    "detail": "total assets equals total liabilities and equity",
    "fields": [
      "totalAssets"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "totalEquity_attribution",
    "detail": "totalEquity excludes noncontrolling interests",
    "fields": [
      "totalEquity"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "netIncome_before_preferred",
    "detail": "net income is not the after-preferred-dividends line",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "epsDiluted_total",
    "detail": "diluted EPS is for total net income",
    "fields": [
      "epsDiluted"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "netIncome_attribution",
    "detail": "netIncome excludes noncontrolling interests",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "cash_flow_tie",
    "detail": "operating + investing + financing (+ FX) equals the net change in cash",
    "fields": [
      "operatingCashFlow",
      "investingCashFlow",
      "financingCashFlow"
    ],
    "passed": true,
    "skipped": false,
    "statement": "cashflow"
  }
]
  6. 5MD&A claims agent3.80s · 2331 tokens · $0.0004
    null
    [
  {
    "kind": "amount_change",
    "field": "revenue",
    "quote": "• Total revenues increased $29.3 billion, or 7.8%, in 2025 compared to 2024. The increase in total revenues was driven by growth across all operating segments.",
    "scope": "consolidated",
    "actual": null,
    "reason": "Total revenue: the sentence is about a region, segment or adjusted measure",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "$29.3 billion",
    "tolerance": null,
    "quoteVerified": true
  },
  {
    "kind": "percent_change",
    "field": "revenue",
    "quote": "• Total revenues increased $29.3 billion, or 7.8%, in 2025 compared to 2024. The increase in total revenues was driven by growth across all operating segments.",
    "scope": "consolidated",
    "actual": null,
    "reason": "Total revenue: the sentence is about a region, segment or adjusted measure",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "7.8%",
    "tolerance": null,
    "quoteVerified": true
  },
  {
    "kind": "amount_change",
    "field": "operatingIncome",
    "quote": "• Operating income decreased $3.9 billion, or 45.3%, in 2025 compared to 2024. The decrease in operating income was primarily due to a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit and the $1.2 billion of legacy litigation charges described above, both recorded during the year ended December 31, 2025. These decreases were partially offset by improved operating performance in the Health Care Benefits segment and the absence of approximately $1.2 billion of restructuring charges recorded in the prior year.",
    "scope": "consolidated",
    "actual": null,
    "reason": "Operating income: the sentence is about a region, segment or adjusted measure",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "$3.9 billion",
    "tolerance": null,
    "quoteVerified": true
  },
  {
    "kind": "percent_change",
    "field": "operatingIncome",
    "quote": "• Operating income decreased $3.9 billion, or 45.3%, in 2025 compared to 2024. The decrease in operating income was primarily due to a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit and the $1.2 billion of legacy litigation charges described above, both recorded during the year ended December 31, 2025. These decreases were partially offset by improved operating performance in the Health Care Benefits segment and the absence of approximately $1.2 billion of restructuring charges recorded in the prior year.",
    "scope": "consolidated",
    "actual": null,
    "reason": "Operating income: the sentence is about a region, segment or adjusted measure",
    "claimed": null,
    "verdict": "not_checked",
    "asWritten": "45.3%",
    "tolerance": null,
    "quoteVerified": true
  }
]

Income statement

table #26 · current period is figure column 1
0For the Years Ended December 31,
1In millions, except per share amounts202520242023
2Revenues:
3Products249,908231,521245,138
4Premiums134,751122,89699,192
5Services15,17516,23912,293
6Net investment income2,2332,1531,153
7Total revenues← Total revenue402,067372,809357,776
8Operating costs:
9Cost of products sold221,167206,287217,098
10Health care costs125,538115,12186,247
11Operating expenses44,97741,70639,832
12Goodwill impairment5,725--
13Restructuring charges-1,179507
14Loss on assets held for sale--349
15Total operating costs397,407364,293344,033
16Operating income← Operating income4,6608,51613,743
17Interest expense(3,119)(2,958)(2,658)
18Gain on early extinguishment of debt-491-
19Gain on deconsolidation of subsidiary483--
20Other income1129988
21Income before income tax provision2,1366,14811,173
22Income tax provision4081,5622,805
23Net income1,7284,5868,368
24Net (income) loss attributable to noncontrolling interests4028(24)
25Net income attributable to CVS Health← Net income attributable to the company1,7684,6148,344
26Net income per share attributable to CVS Health:
27Basic1.403.676.49
28Diluted← Diluted EPS1.393.666.47
29Weighted average shares outstanding:
30Basic1,2671,2591,285
31Diluted1,2711,2621,290

Balance sheet

table #28 · current period is figure column 1
0At December 31,
1In millions, except per share amounts20252024
2Assets:
3Cash and cash equivalents← Cash and cash equivalents8,4538,586
4Investments2,1452,407
5Accounts receivable, net39,77936,469
6Inventories19,24618,107
7Other current assets5,0913,076
8Total current assets74,71468,645
9Long-term investments32,66928,934
10Property and equipment, net13,08312,993
11Operating lease right-of-use assets14,97315,944
12Goodwill85,47891,272
13Intangible assets, net25,50827,323
14Separate accounts assets1,9943,311
15Other assets5,1194,793
16Total assets← Total assets253,538253,215
17Liabilities:
18Accounts payable17,64115,892
19Pharmacy claims and discounts payable26,34424,166
20Health care costs payable15,39915,064
21Accrued expenses and other current liabilities22,38720,810
22Other insurance liabilities1,1161,183
23Current portion of operating lease liabilities1,7371,751
24Short-term debt-2,119
25Current portion of long-term debt4,0683,624
26Total current liabilities88,69284,609
27Long-term operating lease liabilities13,64314,899
28Long-term debt60,50260,527
29Deferred income taxes3,8323,806
30Separate accounts liabilities1,9943,311
31Other long-term insurance liabilities4,7164,902
32Other long-term liabilities4,7775,431
33Total liabilities← Total liabilities178,156177,485
34Commitments and contingencies (Note 18)
35Shareholders’ equity:
36Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding--
37Common stock, par value $0.01: 3,200 shares authorized; 1,787 shares issued and 1,271 shares outstanding at December 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus50,40249,661
38Treasury stock, at cost: 516 and 518 shares at December 31, 2025 and 2024(36,790)(36,818)
39Retained earnings61,19662,837
40Accumulated other comprehensive income (loss)406(120)
41Total CVS Health shareholders’ equity← Total shareholders' equity attributable to the company75,21475,560
42Noncontrolling interests168170
43Total shareholders’ equity75,38275,730
44Total liabilities and shareholders’ equity253,538253,215

Cash flow statement

table #29 · current period is figure column 1
0For the Years Ended December 31,
1In millions202520242023
2Cash flows from operating activities:
3Cash receipts from customers389,128357,995345,464
4Cash paid for inventory, prescriptions dispensed and health services rendered(216,493)(197,726)(208,848)
5Insurance benefits paid(121,238)(109,464)(84,097)
6Cash paid to other suppliers and employees(37,570)(38,821)(34,735)
7Interest and investment income received1,9691,7351,584
8Interest paid(2,991)(2,909)(2,418)
9Income taxes paid(2,166)(1,703)(3,524)
10Net cash provided by operating activities← Net cash from operating activities10,6399,10713,426
11Cash flows from investing activities:
12Proceeds from sales and maturities of investments12,38310,3537,729
13Purchases of investments(15,012)(15,191)(9,043)
14Purchases of property and equipment(2,832)(2,781)(3,031)
15Acquisitions (net of cash and restricted cash acquired)(436)(95)(16,612)
16Other2610168
17Net cash used in investing activities← Net cash from investing activities(5,871)(7,613)(20,889)
18Cash flows from financing activities:
19Commercial paper borrowings (repayments), net(2,119)1,919200
20Proceeds from issuance of short-term loan--5,000
21Repayment of short-term loan--(5,000)
22Proceeds from issuance of long-term debt3,9697,91310,898
23Repayments of long-term debt(3,629)(4,773)(3,166)
24Repurchase of common stock-(3,023)(2,012)
25Dividends paid(3,397)(3,373)(3,132)
26Proceeds from exercise of stock options394361277
27Payments for taxes related to net share settlement of equity awards(158)(185)(181)
28Other-26(201)
29Net cash provided by (used in) financing activities← Net cash from financing activities(4,940)(1,135)2,683
30Net increase (decrease) in cash, cash equivalents and restricted cash(172)359(4,780)
31Cash, cash equivalents and restricted cash at the beginning of the period8,8848,52513,305
32Cash, cash equivalents and restricted cash at the end of the period8,7128,8848,525